MSK Partners With OpenEvidence, Binging OncoKB Precision Oncology Data to Doctors
benxneo · x · 2026-09-17
- Memorial Sloan Kettering Cancer Center (MSK) and OpenEvidence announced a partnership to advance precision oncology.
- The deal includes integrating OpenEvidence into MSK's Epic workflow and bringing OncoKB™, MSK's precision oncology knowledge base, into OpenEvidence for physicians outside MSK.
- OncoKB remains the only somatic cancer variant knowledge base partially recognized by the FDA, pairing curated biomarker evidence with patient context for point-of-care decision support.
More from Companies & People
- Slack launches Slack Code for agentic team coding with 11 agents incl. Replit — amasad · 2026-09-17
- LangChain CEO: our gateway shipped a year too late, sub-agents rarely work as expected — Hacubu · 2026-09-17
- Anthropic merges Claude Chat and Cowork, launches ClaudeDocs and ClaudeSlides — 量子位 · 2026-09-17
- Ex-Microsoft engineer recalls Windows 8 meetings: note app idea met with abuse, then he quit — lmoroney · 2026-09-17
- Manus Launches Global "Learn AI with Manus" Partner Program, Starting with Singapore — parker_lyman · 2026-09-17
- SpaceXAI Marketer to Demo Running End-to-End Campaigns with Grok Bots — chaitu · 2026-09-17